PureTech News

PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer

PureTech Health plc - Half-Year Report

Notice of Half-Yearly Results

PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome

PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders

Results of Annual General Meeting

PureTech Founded Entity Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD

PureTech to Present at the Jefferies Healthcare Conference

PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic